Susan Shi, MD
Obstetrics & Gynecology · Brooklyn, NYNPI 1649354036
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Shield Therapeutics Inc at 26.9% of the total. Reporting peaked in 2024 at $131 and has fallen 53.5% since, to $61 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in NY, where the typical reported total is $302.
Across 16 payments — averaging $22.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shield Therapeutics Inc$97
- Astellas Pharma US Inc$82
- Biogen$47
- Avion Pharmaceuticals$36
- Exeltis, USA Inc.$36
- Exact Sciences$27
- plus $34 from 2 others
What the payments were for
- Food & beverage$359100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shield Therapeutics Inc | 4 | $97 |
| Astellas Pharma US Inc | 3 | $82 |
| Biogen | 2 | $47 |
| Avion Pharmaceuticals | 2 | $36 |
| Exeltis, USA Inc. | 2 | $36 |
| Exact Sciences | 1 | $27 |
| AbbVie | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $13 |
How this compares
$359 in reported general payments places this provider in the 50th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 22 | $429 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Brooklyn
- Miriam CremerBrooklyn$196K
- Michael LewisBrooklyn$62K
- Kathleen MorrellBrooklyn$48K
- Mark DefazioBrooklyn$27K
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Rachel MaschNew York$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.